Thy N. Huynh MD, FAAD
Assistant Professor, Clinical Dermatology & Pediatrics, University of Mississippi Medical Center, Jackson, MississippiDr. Thy Huynh is a double board-certified adult and pediatric dermatologist. She is the only pediatric dermatologist serving the unmet needs of children in the entire state of Mississippi. She graduated from the University of Alabama School of Medicine and completed her dermatology residency at the University of Mississippi Medical Center (UMMC), clinical trials research fellowship at Northwestern University, and pediatric dermatology fellowship at Harvard Medical School/ Boston Children’s Hospital.
She is currently an assistant professor in both Dermatology and Pediatrics and a full faculty member at the School of Graduate Studies in Health Science at UMMC.
Dr. Huynh serves as the chief physician in Pediatric Dermatology and the Medical Director of Clinical Trials in Dermatology. Her research interests include alopecia areata, atopic dermatitis, acne, hidradenitis suppurativa, genetic skin disorders, and skin trends.
Disclosures
Dr. Huynh has no relevant disclosures.Recent Contributions to PracticeUpdate:
- Efficacy and Safety of Upadacitinib vs Dupilumab in Adults and Adolescents With Moderate to Severe Atopic Dermatitis
- Outcomes of Treatment With Upadacitinib Over 1 Month Among Patients With Moderate to Severe Atopic Dermatitis
- Risk Factors of Onset Time and Persistence of Atopic Dermatitis in Children Younger Than 5 Years
- Dupilumab Use for Atopic Dermatitis Is Associated With Decreased Utilization of Psychostimulants for ADHD
- Risk of Melanoma in Patients With Congenital Melanocytic Nevi of All Sizes
- Central Nervous System MRI Abnormalities and Neurologic Outcomes in Pediatric Patients With Congenital Nevi
- Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage
- Secukinumab Therapy for Netherton Syndrome
- Dupilumab Treatment in Severe Allergic Contact Dermatitis Due to Sesquiterpene Lactones
- The Impact of Dupilumab on Patch Testing and the Prevalence of Co-Morbid ACD in Recalcitrant Atopic Dermatitis